New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Alliance Pharma plc
APH.L
Shape
US Flag

LSE

Unprofitable

Unprofitable

230M

Drug Manufacturers - Specialty & Generic

42.55GBP
Shape-0.95 ( -2.18%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

15%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

8%

Quote Panel

Shape
Updated October 6, 2024
1W -2.52 % 1M 4.29 % 3M 15.78 % 1Y 1.55 %

Key Metrics

Shape
  • Market Cap

    230.01M


  • Shares Outstanding

    540.57M


  • Share in Float

    389.70M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    42.55


  • Average Volume

    1.42M


  • Beta

    0.67


  • Range

    24.55-46.0


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.alliancepharmaceuticals.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.27x

P/S Ratio

1.06x

P/B Ratio

0.5

Debt/Equity

-18.3%

Net Margin

$-0.1

EPS

How APH.L compares to sector?

P/E Ratio

Relative Strength

Shape

APH.L

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$202M

Shape6%

2025-Revenue

$0.04

Shape-15%

2025-EPS

$52M

Shape6%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.19

arrow
arrow

N/A

NA
vs NA

Q4.19

arrow
arrow

N/A

0.02
vs NA

Q2.20

arrow
arrow

N/A

NA
vs NA

Q4.20

arrow
arrow

-24%

0.02
vs 0.02

Q2.21

arrow
arrow

N/A

0.02
vs NA

Q4.21

arrow
arrow

N/A

-0.00
vs 0.02

Q2.22

arrow
arrow

+58%

0.02
vs 0.02

Q4.22

arrow
arrow

N/A

-0.02
vs -0.00

Q2.23

arrow
arrow

-100%

NA
vs 0.02

Q4.23

arrow
arrow

N/A

-0.07
vs -0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.20

arrow
arrow

-7%

61.7M  vs 66M

Q4.20

arrow
arrow

-2%

68.1M  vs 69.6M

Q2.21

arrow
arrow

+27%

78.6M  vs 61.7M

Q4.21

arrow
arrow

+24%

84.6M  vs 68.1M

Q2.22

arrow
arrow

+0%

78.8M  vs 78.6M

Q4.22

arrow
arrow

+5%

88.7M  vs 84.6M

Q2.23

arrow
arrow

+3%

81.4M  vs 78.8M

Q4.23

arrow
arrow

+12%

99.3M  vs 88.7M

Q1.24

arrow
arrow

NA

182.4M  vs NA

Q2.24

arrow
arrow

+124%

182.4M  vs 81.4M

Return on EquityShape

status-upQoQ

Q2.20

arrow
arrow

-1%

-0.01
vs 0.05

Q4.20

arrow
arrow

+3%

0.03
vs -0.01

Q2.21

arrow
arrow

+3%

0.03
vs 0.03

Q4.21

arrow
arrow

0%

-0.00
vs 0.03

Q2.22

arrow
arrow

+4%

0.04
vs -0.00

Q4.22

arrow
arrow

-4%

-0.04
vs 0.04

Q2.23

arrow
arrow

+2%

0.02
vs -0.04

Q4.23

arrow
arrow

-18%

-0.18
vs 0.02

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News